Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0003 Transporter Info | ||||
| Gene Name | ABCB1 | ||||
| Transporter Name | P-glycoprotein 1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Pyronaridine Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 107771 | ||||
| Docking Score | -11.33 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C29H32ClN5O2 | ||||
| Molecular Weight | 518 | ||||
| Canonical SMILES |
COC1=NC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NC4=CC(=C(C(=C4)CN5CCCC5)O)CN6CCCC6
|
||||
| InChI |
InChI=1S/C29H32ClN5O2/c1-37-26-9-8-24-28(33-26)27(23-7-6-21(30)16-25(23)32-24)31-22-14-19(17-34-10-2-3-11-34)29(36)20(15-22)18-35-12-4-5-13-35/h6-9,14-16,36H,2-5,10-13,17-18H2,1H3,(H,31,32)
|
||||
| InChIKey | DJUFPMUQJKWIJB-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | 5.3 | Rotatable Bond Count | 7 | |
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 7 | ||
| Xenobiotic Name | Tolvaptan Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 216237 | ||||
| Docking Score | -11.299 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C26H25ClN2O3 | ||||
| Molecular Weight | 448.9 | ||||
| Canonical SMILES |
CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C
|
||||
| InChI |
InChI=1S/C26H25ClN2O3/c1-16-6-3-4-7-20(16)25(31)28-19-10-11-21(17(2)14-19)26(32)29-13-5-8-24(30)22-15-18(27)9-12-23(22)29/h3-4,6-7,9-12,14-15,24,30H,5,8,13H2,1-2H3,(H,28,31)
|
||||
| InChIKey | GYHCTFXIZSNGJT-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | 4.8 | Rotatable Bond Count | 3 | |
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 3 | ||
| Xenobiotic Name | Vinblastine Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 13342 | ||||
| Docking Score | -11.277 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C46H58N4O9 | ||||
| Molecular Weight | 811 | ||||
| Canonical SMILES |
CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
|
||||
| InChI |
InChI=1S/C46H58N4O9/c1-8-42(54)23-28-24-45(40(52)57-6,36-30(15-19-49(25-28)26-42)29-13-10-11-14-33(29)47-36)32-21-31-34(22-35(32)56-5)48(4)38-44(31)17-20-50-18-12-16-43(9-2,37(44)50)39(59-27(3)51)46(38,55)41(53)58-7/h10-14,16,21-22,28,37-39,47,54-55H,8-9,15,17-20,23-26H2,1-7H3/t28-,37-,38+,39+,42-,43+,44+,45-,46-/m0/s1
|
||||
| InChIKey | JXLYSJRDGCGARV-CFWMRBGOSA-N | ||||
| Pharmaceutical Properties | Xlogp | 3.7 | Rotatable Bond Count | 10 | |
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 12 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.